Loading...

Natera, Inc.

NTRA•NASDAQ
Healthcare
Medical - Diagnostics & Research
$203.75
$2.61(1.30%)
U.S. Market opens in 23h 3m

Natera, Inc. (NTRA) Stock Overview

Explore Natera, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap28.9B
P/E Ratio-135.50
EPS (TTM)$-1.52
ROE-0.15%
Fundamental Analysis

AI Price Forecasts

1 Month$218.04
3 Months$221.91
1 Year Target$280.34

NTRA Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Natera, Inc. (NTRA) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 50.73, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $280.34.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -135.50 and a market capitalization of 28.9B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
1.30%
5-Day Change
1.80%
1-Month Change
4.75%
3-Month Change
-15.66%
6-Month Change
5.84%
Year-to-Date (YTD) Change
-11.06%
1-Year Change
31.89%
3-Year Change
284.43%
5-Year Change
75.77%
All-Time (Max) Change
1031.94%

Contact Information

https://www.natera.com
650 249 9090
13011 McCallen Pass Building A, Austin, CA, 78753

Company Facts

4,424 Employees
IPO DateJul 1, 2015
CountryUS
Actively Trading

Frequently Asked Questions